Testing high-flow oxygen for migraine in the emergency room
Part of Brain & nervous system clinical trials.
This trial looks at whether breathing high-flow oxygen in the emergency department can help relieve migraine-like headaches. You may qualify if you are 18+ and are admitted to the ER for a migraine that fits standard diagnostic rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have French public health insurance
- Be admitted to the emergency department for a migraine-type headache that matches standard criteria
- Be able to sign a consent form in writing
- Not have COPD or other long-term breathing failure problems
- Not have taken a triptan within the past 2 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
This trial tests whether hands-on osteopathic treatment can help reduce migraines. If you're an adult aged 18–50 with frequent migraines, you might benefit from seeing if this non-drug approach eases your symptoms.
This trial tests whether a combination of physical therapy techniques can reduce migraine symptoms. It may help people whose migraines are not caused by other conditions.
This trial tests whether physiotherapy (physical therapy) can help reduce migraine symptoms. It focuses on people diagnosed with migraine by a neurologist, excluding those with other headache types or certain health conditions.
This trial tests a new nasal spray, PRT-064040, to see if it can help treat migraine attacks. It is for adults who have had migraines for at least a year and get 2 to 8 moderate to severe migraines per month.
This study tests an add-on migraine medicine (eptinezumab) given in the emergency room to quickly relieve a migraine attack, in addition to the usual care. It aims to see if this approach reduces pain and prevents the migraine from coming back.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.